Analytical instruments and laboratory platform

Agilent Technologies, Inc.

Agilent Technologies sells analytical instruments, consumables, software, laboratory services, and pharmaceutical API development and manufacturing services to pharmaceutical, biopharma, clinical diagnostics, chemicals, and advanced-materials customers. Its cloud genomics workflows use AWS compute and NVIDIA acceleration, while the BIOVECTRA acquisition expanded its biopharmaceutical CDMO capabilities.

A Updated Sep 12, 2026 3 AI consumers· 3 recurring

Per the valuechain.wiki graph, Agilent Technologies, Inc. is directly linked to 4 companies (2 supply, 2 revenue relationships) and reaches 49 companies within two hops; the links are backed by 6 dated sources, 2 of them primary filings (as of 2026-09-12).

Annual return · 2026-09-04'21+35.5%'22-5.5%'23-6.4%'24-2.7%'25+1.9%YTD+11.5%
Agilent Technologies, Inc.FY2025 total revenue of $6.948 billion
Money outAmazonNVIDIA

Financials & Segments

  • Total revenue · FY2025 total revenue of $6.948 billion (SEC Form 10-K)
  • Segments · Life Sciences and Diagnostics Markets · Agilent CrossLab · Applied Markets

Revenue from

  • Alnylam Pharmaceuticals High confidence
    Alnylam sources the active pharmaceutical ingredients for AMVUTTRA, ONPATTRO, and GIVLAARI from Agilent. Alnylam's FY2025 Form 10-K names Agilent as the sole API manufacturer for all three products but does not disclose transaction value or supply percentages.
    Confirms EN SEC EDGAR Published Feb 12, 2026: Alnylam Pharmaceuticals FY2025 Form 10-K
    Confirms KO SK Securities Published Sep 1, 2022: RNA Renaissance
  • Pfizer Inc. Medium confidence
    A Pfizer 24/7 production site used a dedicated Agilent CrossLab team for instrument maintenance, qualification, compliance, and asset monitoring. The contract value and revenue attributable to Agilent were not disclosed.
    Confirms EN Agilent Technologies Published Dec 13, 2021: Agilent Pharmaceutical Case Study: Pfizer

Pays to

  • Amazon Medium confidence
    Agilent uses Amazon EC2 G5g instances for genomic variant-calling workflows in its cloud-native Alissa Reporter software. AWS spending and contract terms were not disclosed.
    Confirms EN Agilent Technologies Published Jun 7, 2022: Agilent Leverages NVIDIA and AWS Technology to Improve Analysis Speeds of Genomics Bioinformatics Pipelines
  • NVIDIA Medium confidence
    Agilent integrated NVIDIA T4G GPUs and Clara Parabricks acceleration into Alissa Reporter's variant-calling pipelines. The technology cost and commercial terms were not disclosed.
    Confirms EN Agilent Technologies Published Jun 7, 2022: Agilent Leverages NVIDIA and AWS Technology to Improve Analysis Speeds of Genomics Bioinformatics Pipelines

Investments

  • BIOVECTRA High confidence· Amount $915M · acquisition completed 2024-09-20 · Cash consideration paid to acquire 100% of BIOVECTRA
    Agilent acquired 100% of BIOVECTRA in September 2024, adding biologics, highly potent API, and targeted-therapeutics CDMO capabilities. Its FY2025 Form 10-K records $915 million of cash consideration.
    Confirms EN SEC EDGAR Published Dec 22, 2025: Agilent Technologies FY2025 Form 10-K
    Confirms EN Agilent Technologies Published Sep 20, 2024: Agilent Completes Acquisition of BIOVECTRA

Value-chain ripple (2 tiers)

Following node-to-node links up to 2 tiers; each firm is shown once, at its nearest tier.

CompanyChain'21'22'23'24'25YTD
Cardinal Health, Inc.lead2-0.4+54.1+34.1+19+76.3+21.1
McKesson Corporationlead2+44.2+51.8+24.1+23.7+44.5+11
Cencora, Inc.lead2+44.1+26.3+25.3+10.4+51.5-1.4
Pfizer Inc.lead1+66.7-10.4-41.3-2.2+0.6+20.2
Alnylam Pharmaceuticalslead1+30.5+40.1-19.5+22.9+69-33.1
Agilent Technologies, Inc.node+35.5-5.5-6.4-2.7+1.9+11.5
Amazonbenef1+2.4-49.6+80.9+44.4+5.2+12
SanDiskbenef2·····+633
Seagate Technologybenef2+87.5-51.4+69.1+4.1+225.3+209.1
Marvellbenef2+84.6-57.5+63.7+83.8-22.8+163.4
Wiwynnbenef2+24.7-22.3+206.4+3.5+64.4+120.2
Astera Labsbenef2····+25.6+86.6
Corningbenef2+5.9-11.6-1.2+60.6+87.8+77.2
Arista Networksbenef2+97.9-15.6+94.1+87.7+18.5+47.9
Occidental Petroleumbenef2+67.7+119.1-4.1-15.9-14.9+47.4
GE Vernovabenef2····+99+44.4
Caterpillarbenef2+16+18.6+25.9+24.7+60.3+42.9
FedExbenef2+0.7-31.6+49.1+13.5+5.1+39.6
Cienabenef2+45.6-33.8-11.7+88.4+175.8+37.3
Jabilbenef2+66.4-2.5+87.4+13.3+58.7+36.3
Alchip Technologiesbenef2+14.3-8.7+365.1-18.9+0.8+36.1
Globalstarbenef2+241.2+14.7+45.9+6.7+96.6+34.9
Eatonbenef2+46.7-7.2+56.2+39.5-2.8+30.1
Quanta Computerbenef2+22.2-12.8+254.5+12.7+8.9+28.5
Digital Realtybenef2+30.7-41+39.9+35.9-10.1+23.4
Schneider Electricbenef2+25.9+1.6+25.8+36.1+0.5+20.7
Foxconn (Hon Hai)benef2-5.1+2.8+7.8+80.1+26.9+19.6
Credo Technologybenef2··+46.3+245.2+114.1+18.5
ABBbenef2+23.9+7.3+18.9+39+36.1+18.4
Entergybenef2+17.1+3.6-6.1+56+25.3+18.2
Norfolk Southernbenef2+27.3-15.6-1.6+1.6+25.6+15.6
Colgate-Palmolive Companybenef2+2.1-5.4+3.8+16.6-11+14.4
Cumminsbenef2-1.7+14.1+1.7+48.9+49.4+11
United Parcel Service, Inc.benef2+30-16.2-6-15.9-15.9+8
Celesticabenef2+37.9+1.3+159.8+215.2+220.3+5.7
Procter & Gamblebenef2+20.5-5-0.9+17.3-12.3+4.5
Amorepacificbenef2-30.1-5.7-18.4+9.9+8.2+4.1
Exelonbenef2+41.5+8.3-14+9.2+20+1.9
Vistrabenef2+19.6+5.1+70.7+261.5+17.7-7.2
Fabrinetbenef2+52.7+8.2+48.4+15.5+107.1-10.5
IonQbenef2·-79.3+259.1+237.1+7.4-11.9
Abbott Laboratoriesbenef2+30.5-20.7+2.3+4.8+12.9-11.9
Talen Energybenef2···+214.8+86.1-15.4
Quantum Computing Incbenef2-75.8-55.7-39.5+1712.7-38-21.9
D-Wave Quantumbenef2·-85.3-38.9+854.5+211.3-36.6
Nikebenef2+18.7-29-6-29.1-13.8-38.1

YTD as of 2026-09-04 · source: Yahoo Finance

Agilent Technologies, Inc. operates across Analytical instruments and laboratory platform. It is +11.5% in 2026. Demand side (avg +20.2%), the stock (+11.5%) and supply side (avg +17.9%) are moving in step. Propagation has completed a lap, so the next leg depends on individual results more than chain direction. Among connected nodes the furthest ahead is NVIDIA (+23.7%) and the furthest behind is Amazon (+12%). If chain logic explains the gap, the laggard is the next propagation candidate; if not, the link itself deserves a second look. Its cloud genomics workflows use AWS compute and NVIDIA acceleration, while the BIOVECTRA acquisition expanded its biopharmaceutical CDMO capabilities.

Analysis generated from returns as of 2026-09-04

← All companiesMarkdown · JSON

For information only, not investment advice. Content on this site is generated by AI from verified, cross-checked sources and may contain errors.

© 2026 Willow Investments, Inc.Company value-chain data · contact@willowinvt.com